Presbycusis
21
3
3
14
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 21 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
57%
8 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (21)
Impact of Auditory Stimulation in Eating Pleasure (EDERE 2021)
Evaluation of the Impact of Cochlear Implants on Cognition in Older Adults
Age-related Hearing Loss and Lexical Disorders
Efficacy and Safety of Liuwei Dihuang Pill Versus Placebo in Presbycusis With Shen (Kidney)-Yin Deficiency
Clinical Trial on Alzheimer Disease, Presbycusis and Hearing Aids
Improving Speech in Noise Perception for Individuals With Age-related Hearing Loss
Audiovestibular Function in Infratentorial Superficial Siderosis
Barriers and Facilitators to OTC Hearing Aids Success
Impact of Hearing Aid Service-delivery Model and Technology on Patient Outcomes
Effects of Huperzine a on Presbycusis(Δ,kHz, DB,MMSE, AD)
Longitudinal Outcomes of Hearing Aids
Hearing and Cognition in Aging Adults
FX-322 in Adults With Age-Related Sensorineural Hearing Loss
Study of the Association Between Presbycusis With the Incidence of Frailty
Variability In Hearing Aid Outcomes In Older Adults
Evaluating Hearing Aid Service Delivery Models
At-home Auditory Training Clinical Trial
Mitochondrial Genetics of Presbycusis
Computer-Based Auditory Rehabilitation
Predicting Success With Hearing Aids